articleTop 10% cited
Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management
Atherosclerosis · 1999 · Vol. 142(1) · pp. 105–112
Lipoproteins and Cardiovascular HealthCancer, Lipids, and MetabolismAntiplatelet Therapy and Cardiovascular DiseasesMedicineRelative riskAbsolute risk reductionInternal medicinePopulationConfidence intervalCohortDemographyCohort studyCoronary heart disease
MeSH terms
AdultAgedCause of DeathCoronary DiseaseFemaleFollow-Up StudiesHeterozygoteHumansHyperlipoproteinemia Type IIMaleMiddle AgedRisk FactorsCohort Studies
Citations
399
FWCI
11.46
field-weighted impact
References
29
Percentile
99%
vs. same field & year
Citations per year
Cited by
Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia
Atherosclerosis · 2004 · 495 citations
A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia
Atherosclerosis · 2003 · 566 citations
JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice
Heart · 2005 · 1,218 citations
References
Cardiovascular disease risk profiles
American Heart Journal · 1991 · 2,171 citations
Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge
Clinical Chemistry · 1972 · 32,293 citations
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
New England Journal of Medicine · 1995 · 7,469 citations
The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
New England Journal of Medicine · 1996 · 7,478 citations
The Metabolic Basis of Inherited Disease.
Annals of Internal Medicine · 1983 · 2,697 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.